SciClone Pharmaceuticals, Inc. Stock

Stocks

17-10-13	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone	PR
17-08-29	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017	BU
17-08-17	Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN	PR
17-08-16	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma	PR
17-08-10	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+2.16%	+3.17%	+43.57%	+160.28%	1,035B
JOHNSON & JOHNSON	-0.07%	+4.45%	+53.50%	+48.95%	574B
ABBVIE INC.	-0.08%	-0.08%	+17.37%	+62.66%	397B
ROCHE HOLDING AG	+0.31%	+0.77%	+21.19%	+15.95%	324B
ASTRAZENECA PLC	+1.23%	-0.64%	+24.84%	+16.40%	281B
NOVARTIS AG	+0.63%	+4.14%	+25.28%	+35.25%	278B
NOVO NORDISK A/S	+0.50%	+4.87%	-45.06%	-47.85%	193B
AMGEN INC.	+4.84%	+2.45%	+21.33%	+61.85%	191B
GILEAD SCIENCES, INC.	+3.61%	-2.56%	+15.16%	+61.12%	156B
Average	+1.34%	+1.68%	+19.69%	+46.07%	381.1B
Weighted average by Cap.	+1.29%	+2.39%	+29.54%	+73.07%

Employees

Sector